Rhenman & Partners Asset Management Ab Abbott Laboratories Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Abbott Laboratories stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 135,000 shares of ABT stock, worth $15.2 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

135,000

Previous 145,000 6.9%

Holding current value

$15.2 Million

Previous $15.1 Million 2.16%

% of portfolio

1.28%

Previous 1.49%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $1 Million - $1.18 Million	-10,000 Reduced 6.9%	135,000 $15.4 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $4.03 Million - $4.5 Million	-40,000 Reduced 21.62%	145,000 $15.1 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $2.19 Million - $2.42 Million	-20,000 Reduced 9.76%	185,000 $21 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $5.11 Million - $6.26 Million	-56,675 Reduced 21.66%	205,000 $22.6 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $1.21 Million - $1.45 Million	12,675 Added 5.09%	261,675 $25.3 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $6.45 Million - $7.19 Million	64,000 Added 34.59%	249,000 $27.1 Million
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $6.59 Million - $7.75 Million	68,000 Added 58.12%	185,000 $18.7 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $5.13 Million - $5.94 Million	-53,000 Reduced 31.18%	117,000 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $8.17 Million - $9.87 Million	80,000 Added 88.89%	170,000 $18.5 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $1.14 Million - $1.39 Million	-10,000 Reduced 10.0%	90,000 $10.7 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $12.2 Million - $15 Million	-106,000 Reduced 51.46%	100,000 $14.1 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $5.13 Million - $5.68 Million	-44,000 Reduced 17.6%	206,000 $24.3 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $2.64 Million - $3.11 Million	-25,000 Reduced 9.09%	250,000 $29 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $13.6 Million - $16 Million	125,000 Added 83.33%	275,000 $33 Million
Q4 2020 Jan 19, 2021	SELL	$105.0 - $114.42 $5.78 Million - $6.29 Million	-55,000 Reduced 26.83%	150,000 $16.4 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $1.83 Million - $2.23 Million	20,000 Added 10.81%	205,000 $22.3 Million
Q2 2020 Jul 16, 2020	BUY	$76.57 - $98.0 $1.15 Million - $1.47 Million	15,000 Added 8.82%	185,000 $16.9 Million
Q1 2020 Apr 16, 2020	SELL	$62.82 - $91.86 $2.35 Million - $3.44 Million	-37,469 Reduced 18.06%	170,000 $13.4 Million
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $992,758 - $1.11 Million	-12,645 Reduced 5.74%	207,469 $18 Million
Q3 2019 Oct 16, 2019	SELL	$81.84 - $88.74 $3.23 Million - $3.5 Million	-39,438 Reduced 15.19%	220,114 $18.4 Million
Q1 2019 Apr 11, 2019	SELL	$66.22 - $80.06 $331,100 - $400,300	-5,000 Reduced 1.89%	259,552 $20.7 Million
Q3 2018 Oct 03, 2018	BUY	$60.81 - $73.36 $3.2 Million - $3.86 Million	52,552 Added 24.79%	264,552 $19.4 Million
Q2 2018 Jul 20, 2018	BUY	$57.57 - $63.54 $575,700 - $635,400	10,000 Added 4.95%	212,000 $12.9 Million
Q1 2018 Apr 11, 2018	BUY	$56.27 - $63.62 $4.5 Million - $5.09 Million	80,000 Added 65.57%	202,000 $12.1 Million
Q4 2017 Jan 19, 2018	SELL	$53.68 - $57.47 $1.77 Million - $1.9 Million	-33,000 Reduced 21.29%	122,000 $6.96 Million
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $7.45 Million - $8.31 Million	155,000	155,000 $8.27 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Abbott Laboratories Transaction History